Artelo Biosciences Financials

Artelo Biosciences Stock Summary

Artelo Biosciences competes with Eyenovia, Arrowhead Pharmaceuticals, Krystal Biotech, BioNTech, and Moderna. Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Artelo Biosciences is traded on BATS Exchange in USA.

Artelo Biosciences Key Financial Ratios

Artelo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Artelo Biosciences's current stock value. Our valuation model uses many indicators to compare Artelo Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Artelo Biosciences competition to find correlations between indicators driving Artelo Biosciences's intrinsic value. More Info.Artelo Biosciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Artelo Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.